Cladribine, high-dose cytarabine, plus gemtuzumab ozogamicin (CLAG-GO) as frontline intensive therapy for fit patients with core-binding factor acute myeloid leukemia. - Azevedo, Roberta S.; Braish, Julie; Gener-Ricos, Georgina; Tang, Guilin; Sasaki, Koji; Montalban-Bravo, Guillermo; Jabbour, Elias; Ohanian, Maro; Yilmaz, Musa; Haddad, Fadi G.; Chien, Kelly; Ishizawa, Jo; et al. (Leukemia & Lymphoma, 2026)